Table 1 The demgraphic characteristics of 321 PGT-FET cycles
From: Should non-invasive prenatal testing be recommended for patients who achieve pregnancy with PGT?
Parameters | Group 1 (n = 138) | Group 2 (n = 183) | P-value |
|---|---|---|---|
Age (years) | 31.04 ± 4.15 | 35.64 ± 4.74 | < 0.000 |
BMI (kg/m2) | 21.56 ± 3.04 | 21.94 ± 2.70 | 0.277 |
Basal FSH ( IU/L) | 6.19 ± 2.15 | 6.27 ± 2.13 | 0.525 |
Basal E2 (pg/ml) | 141.03 ± 86.28 | 157.27 ± 205.46 | 0.680 |
Basal LH ( IU/L) | 4.30 ± 2.68 | 3.40 ± 1.88 | 0.003 |
AMH (ng/mL) | 5.55 ± 11.22 | 4.09 ± 3.55 | 0.012 |
Endometrial thickness (mm) | 9.78 ± 1.49 | 9.67 ± 1.51 | 0.600 |
Stimulation duration (days) | 10.61 ± 1.35 | 10.19 ± 1.73 | 0.008 |
Total Gn dose (IU) | 2363.04 ± 792.94 | 2412.24 ± 833.61 | 0.583 |
β-HCG (IU/L) | 920.28 ± 575.19 | 949.39 ± 747.09 | 0.837 |